What are the side effects of CJC-1295 (no DAC)?
The most commonly reported CJC-1295 (no DAC) side effects are head-rush, brief facial flush, hunger pulse. Most are mild and tend to be dose dependent. It is generally avoided with active malignancy. Human clinical evidence for CJC-1295 (no DAC) is limited, so this reflects reported and observed effects, not a complete safety profile.
Reported CJC-1295 (no DAC) side effects
- Head-rush
- Brief facial flush
- Hunger pulse
Who should avoid it
- Active malignancy
- Pregnancy / nursing
Bloodwork worth tracking
- IGF-1 baseline + week 8
References
- Prolonged stimulation of GH and IGF-I secretion by CJC-1295 — Teichman SL et al., JCEM, 2006
- Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog — Jetté L et al., Endocrinology, 2005
- Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications — Villegas Meza AD et al., JBJS Reviews, 2026
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on CJC-1295 (no DAC)
Last updated 2026-06-06.